Therefore, we first administrated immunogenic SARS-CoV-2 peptides from spike, membrane, nucleocapsid, and envelope protein to A/JOla mice, susceptible to autoimmune diseases, in order to investigate their pathogenic immunologic potential on the heart and other organs (lung, liver, kidney, intestine, and muscle). This evidence concerns the gene ERVW-1 and autoimmune disease.